Indian Pharmaceutical Industry in 2018-SWOT Analysis

Authors

  • Lata Khani Bisht
  • Blessy Jacob
  • Vineeth Chandy

Keywords:

Opportunity, strength, threat, weakness

Abstract

The top Pharmaceutical companies in India in currently are Glenmark, Glaxo Smith Kline, Cadila healthcare, Aurobindo Pharma, Cipla, Lupin, Dr Reddy’s, and Sun Pharma etc. The strength, weakness, opportunities and threats associated with them and altogether to this industry is of great interest to pharma and commerce industry equally. The world population explosion and increase in life span has increased the importance of this industry overtime. The spending on medicine and healthcare by governments have pushed it further to new heights. But still lot needs to be done to make medicine available to the lowest downtrodden person. Immunization program needs to be carried for each and every household in India. As the competition in the pharma field has increased considerably, “Talent to Value” approach needs to be followed.

 

Additional Files

Published

2018-10-10

How to Cite

Bisht, L. K., Jacob, B., & Chandy, V. (2018). Indian Pharmaceutical Industry in 2018-SWOT Analysis. NOLEGEIN-Journal of Global Marketing, 1(2), 7–11. Retrieved from https://mbajournals.in/index.php/JoGM/article/view/156